Skip to main content
. 2015 Jul 16;7:707–716. doi: 10.2147/IJWH.S83418

Figure 3.

Figure 3

Mean serum concentrations of XM17 after single ascending doses administered subcutaneously to healthy females. Values are corrected for pre-dose follicle-stimulating hormone levels (log-linear scale).